Immunology

Study Investigates Incidence Rates of Adverse Events in Alopecia Areata

A recent study provides a comprehensive analysis of the incidence rates of infections, malignancies, thromboembolism, and cardiovascular events in alopecia areata patients, contributing crucial insights to optimize treatment strategies and patient management. The study identified a higher incidence rate of herpes simplex infection among patients with alopecia areata compared to the matched non-alopecia areata cohort....

Physician Perspectives on Alopecia Areata Treatment Decision-Making

A new study explores the values and attitudes of physicians when helping patients choose an alopecia areata treatment. It may reveal the complexities of decision-making, potential communication barriers, and the possible role of shared decision-making tools. Alopecia areata treatment decision-making involves considering a variety of treatment factors and patient characteristics. Physicians express the need for...

How Trained Immunity and Vitiligo Are Connected

Recent studies suggest that trained immunity, a state of heightened immune response, could affect vitiligo. This new perspective could greatly impact our understanding of vitiligo’s progression and change how we approach new treatment options. Vitiligo is an autoimmune reaction to the pigment-producing cells in the skin that leads to loss of skin pigmentation. Both innate...

Can Chemical Exposure Cause Vitiligo?

For those living with vitiligo, understanding potential triggers and causes can be empowering. A recent study suggests that exposure to certain chemicals might be strongly linked to the development and progression of vitiligo. Knowing this may help in managing the condition. Vitiligo, a condition characterized by skin depigmentation, is thought to be triggered by a...

Your Risk of Thyroid Disorders With Vitiligo

Recent research shows a significant link between vitiligo, a skin condition, and autoimmune thyroid disorders. Discover what this connection means for you and how you can manage your health more effectively. There’s a notable connection between vitiligo and the onset of thyroid disorders. Regular screening for thyroid autoantibodies is recommended if you have vitiligo. Vitiligo...

Eyes on Vitiligo: The Impact of Vitiligo on Your Eye Health

A comprehensive review sheds light on the impact vitiligo can have on your eye health. This information may help you manage your eye health effectively and understand why regular eye check-ups are important. Vitiligo may affect your eye health in addition to causing a loss of skin pigmentation. Dry eye disease and changes in eye...

Probiotics: A Potential Ally Against Children’s Eczema

Evidence suggests single-strain probiotics, particularly lactobacilli, may help reduce symptoms of atopic dermatitis, a common type of eczema, in children. This article explores an analysis of the latest scientific findings and how these beneficial bacteria may act as a supportive treatment for skin health. Certain single-strain probiotics, notably lactobacilli and others, can help reduce the...

Rituximab vs. Oral Immunosuppressive Therapies for NMOSD

This study demonstrated the relatively greater efficacy of rituximab for preventing relapses in neuromyelitis optica spectrum disorder patients than administering oral immunosuppressive agents. Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory autoimmune disorder associated with high levels of disability and relapses. Despite the high disease prevalence in this population, Black patients are consistently underrepresented in...

Efficacy and Safety of Monoclonal Antibody Therapy in Patients With NMOSD

Off-label and approved monoclonal antibodies are associated with a significantly lower risk of relapse compared to standard treatments. Off-label monoclonal antibodies can be utilized in resource-limited settings. Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating condition involving the central nervous system (CNS). Both off-label and Food and Drug Administration (FDA)-approved monoclonal antibodies (mAbs) are...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.